Handelsinvest Investeringsforvaltning Sells 2,333 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Handelsinvest Investeringsforvaltning reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 35.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,266 shares of the biopharmaceutical company’s stock after selling 2,333 shares during the period. Handelsinvest Investeringsforvaltning’s holdings in Regeneron […]

Related Keywords

Canada ,George Yancopoulos ,N Anthony Coles ,Handelsinvest Investeringsforvaltning ,Robertw Baird ,Quarter For Regeneron Pharmaceuticals ,Securities Exchange Commission ,Nasdaq ,Regeneron Pharmaceuticals ,Anderson Hoagland Co ,Regeneron Pharmaceuticals Price Performance ,Moody National Bank Trust Division ,Regeneron Pharmaceuticals Inc ,Jpmorgan Chase Co ,Riggs Asset Managment Co ,News Ratings For Regeneron Pharmaceuticals Daily ,Janiczek Wealth Management ,Wells Fargo Company ,Royal Bank ,Get Rating ,Asset Managment ,National Bank Trust Division ,Wealth Management ,Directorn Anthony Coles ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,